Dermatological Drugs: United States

 
   Single User - $750
   Corporate License - $1,050


Loading...
Published Jun 30, 2017 | 29 Pages | Pub ID: FFO15525722

Dermatological Drugs: United States

This report forecasts US demand in 2021 for prescription dermatological drugs by product in nominal US dollars at the manufacturers' level. Product segments include antiaging and photodamage drugs, psoriasis drugs, antifungal drugs, skin cancer drugs, acne and rosacea drugs, dermatitis and seborrhea drugs, hair loss and hair removal drugs, hyperpigmentation/melasma and depigmenting drugs, and other products.

To illustrate historical trends, total demand and the various segments are provided for 2016.
  • Highlights
  • Market Environment
    • Introduction
    • Dermatological Conditions & Treatment
      • Table Common Bases for Topical Dermatological Medications
    • Regulatory Factors
  • Segmentation & Forecasts
    • Products
      • Table Figure 1 | US Dermatological Drug Demand by Product; 2016, 2021
      • Table US Dermatological Drug Demand by Product; 2016, 2021
      • Antiaging & Photodamage Drugs
      • Psoriasis Drugs
      • Antifungal Drugs
      • Skin Cancer Drugs
      • Acne & Rosacea Drugs
      • Dermatitis & Seborrhea Drugs
      • Hair Loss & Hair Removal Drugs
      • Hyperpigmentation/Melasma & Depigmenting Drugs
      • Other Skin Disorder Drugs
        • Table Figure 2 | US Dermatological Drug Demand by Product; 2016, 2021
  • Industry Structure
    • Industry Characteristics
    • Market Leaders
      • Table Select Suppliers to the US Dermatological Drug Market
      • Allergan
      • Merck & Company
      • Novartis Pharmaceuticals Corporation
  • About This Report
    • Scope & Method
    • Sources
    • Industry Codes
      • Table Industry Codes Related to Dermatological Drugs
    • Resources